JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study

Dermatology and Therapy · Published 2026-07-25 · DOI 10.1007/s13555-026-01867-y

Free full text

Authors (11)

Paola Facheris, Luigi Gargiulo, Luciano Ibba, Mario Valenti, Francesco D’Oria, Giulio Foggi, Costanza Falcidia, Sara Di Giulio, Carlo A. Vignoli, Antonio Costanzo, Alessandra Narcisi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Facheris, P., Gargiulo, L., Ibba, L., et al. (2026). JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study. Dermatology and Therapy. https://doi.org/10.1007/s13555-026-01867-y

Related articles

• Long-term benefits of upadacitinib for Atopic Dermatitis: deep responses in patient-reported outcomes over 140 weeks from the Measure Up 1 and Measure Up 2 clinical trials · Journal of Dermatological Treatment · 2026 · Cites or is cited by this article
• Consensus Recommendations for Management of Darier Disease: A Practical Approach · Dermatology and Therapy · 2026 · Same journal
• Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy · Dermatology and Therapy · 2026 · Same journal
• Characteristics of Dupilumab-Treated Patients with Atopic Dermatitis Over Time: A Cross-Sectional Assessment of Potential Channeling Bias upon Pediatric Label Extension · Dermatology and Therapy · 2026 · Same journal
• Patient Preferences for Treatment Attributes in Moderate to Severe Chronic Hand Eczema: A Discrete Choice Experiment · Dermatology and Therapy · 2026 · Same journal
• Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo · Dermatology and Therapy · 2026 · Same journal
• Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study · Dermatology and Therapy · 2026 · Same journal
• Itch, Scratching, and Sleep Mediate the Association between Disease Severity and Quality of Life in Pruritic Dermatoses: A Cross-Sectional Study · Dermatology and Therapy · 2026 · Same journal
• Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region · Dermatology and Therapy · 2026 · Same journal
• Immunobiological Therapy in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study Investigating the Effects of Inadequate Therapeutic Compliance on Drug Survival · Dermatology and Therapy · 2026 · Same journal